Mikra Announces Joint Product with Jose Bautista

Mikra Completes Formulation of its First Joint Product with MLB Legend Jose Bautista

TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased to announce that its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra") has completed formulation of its first joint product with six time MLB All-Star, three time Silver Slugger and Olympic medal winner Jose Bautista. Mikra’s new product FOCUS combines a precision blend of citicoline, tyrosine and pure lion's mane mushroom to deliver superior clarity of cognition and improved memory without any caffeine or stimulants. The Mikra team has had the pleasure of working closely with Mr. Bautista throughout a comprehensive development process during which we extensively researched and evaluated a range of active ingredients and dosage combinations in order to arrive at the optimal formula for FOCUS. We deeply appreciate his contributions as an elite athlete with unique insights into achieving peak human performance.

“It’s been a blast working with Team Mikra on developing FOCUS,” said Jose Bautista. “Now that R&D is complete, I’m looking forward to seeing FOCUS hit shelves later this year so that everyone can enjoy the difference this formula makes in your day, a difference you can really feel.”

“FOCUS will continue to deliver on our commitment to introducing science-backed natural solutions to everyday concerns,” added Meni Morim, CEO of Lifeist. “It is an absolute pleasure to be collaborating with Jose Bautista to develop FOCUS, leveraging his experience both as an accomplished entrepreneur and as an elite athlete with extensive firsthand knowledge of cutting-edge nutraceutical supplementation. We’re confident that our customers will appreciate the lasting effectiveness of FOCUS, without the jitters and crashes that other products – that rely on stimulants like caffeine – are known for. We have now sent the formulation to our 100% U.S. manufacturer and look forward to delivering our first customer orders at the start of the fourth quarter of this year.”